Total | Canada | Greece | Hungary | The Netherlands | South Africa | UK | |
Parents interviewed n | 1284 | 228 | 225 | 225 | 206 | 200 | 200 |
Female parents | 87 | 81 | 85 | 98 | 83 | 91 | 82 |
p-value¶ | 0.007 | 0.512 | 0.001 | 0.090 | 0.084 | 0.034 | |
Age distribution of parent yrs | |||||||
18–24 | 1 | 1 | 1 | 3 | |||
25–34 | 23 | 25 | 10 | 40 | 14 | 28 | 23 |
35–44 | 53 | 50 | 64 | 49 | 53 | 44 | 55 |
45–54 | 20 | 21 | 25 | 9 | 31 | 15 | 21 |
55–64 | 2 | 3 | 2 | 1 | 7 | 2 | |
≥65 | 3 | ||||||
Female children/adolescents | 40 | 39 | 34 | 38 | 41 | 54 | 38 |
p-value¶ | 0.713 | 0.049 | 0.441 | 0.951 | 0.001 | 0.592 | |
Age distribution of child/adolescent yrs | |||||||
4–7 | 27 | 30 | 22 | 22 | 26 | 25 | 35 |
8–10 | 26 | 25 | 22 | 29 | 25 | 25 | 29 |
11–13 | 26 | 23 | 22 | 35 | 28 | 26 | 22 |
14–15 | 22 | 21 | 34 | 14 | 21 | 24 | 15 |
Infant mortality rate deaths per 100000 | NA | 5.0 | 4.0 | 6.0 | 4.0 | 46.0 | 4.4 |
Smoker in household | 44 | 36 | 33 | 53 | 32 | 48 | 31 |
Reported smoking within house | 9 | 11 | 11 | 4 | 8 | 9 | 11 |
C-ACT score+ | 19.8±4.3 | 19.4±4.3 | 20.6±4.3 | 20.1±4.3 | 20.1±3.7 | 17.7±4.1 | 20.8±4.4 |
Inhaled corticosteroid use | 67 | 75 | 58 | 82 | 72 | 41 | 69 |
Inhaled LABA use | 22 | 15 | 11 | 40 | 27 | 24 | 16 |
Leukotriene receptor antagonist use | 15 | 13 | 7 | 51 | 9 | 2 | 6 |
Data are presented as % or mean±sd, unless otherwise stated. C-ACT: Childhood-Asthma Control Test; LABA: long-acting β2-agonist; NA: not available. #: parent report and n=1,284 throughout except for C-ACT data; ¶: p-values represent each country compared with the rest of the countries combined; +: n=844.